BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28002638)

  • 1. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
    Lanvers-Kaminsky C; Zehnhoff-Dinnesen AA; Parfitt R; Ciarimboli G
    Clin Pharmacol Ther; 2017 Apr; 101(4):491-500. PubMed ID: 28002638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.
    Lanvers-Kaminsky C; Ciarimboli G
    Pharmacogenomics; 2017 Dec; 18(18):1683-1695. PubMed ID: 29173064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding drug ototoxicity: molecular insights for prevention and clinical management.
    Yorgason JG; Fayad JN; Kalinec F
    Expert Opin Drug Saf; 2006 May; 5(3):383-99. PubMed ID: 16610968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
    Kros CJ; Steyger PS
    Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 30559254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.
    Schacht J; Talaska AE; Rybak LP
    Anat Rec (Hoboken); 2012 Nov; 295(11):1837-50. PubMed ID: 23045231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis.
    Núñez-Batalla F; Jáudenes-Casaubón C; Sequí-Canet JM; Vivanco-Allende A; Zubicaray-Ugarteche J
    Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(4):255-265. PubMed ID: 35872300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ototoxicity.
    Rybak LP; Ramkumar V
    Kidney Int; 2007 Oct; 72(8):931-5. PubMed ID: 17653135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drug-induced hearing loss as a manifestation of drug-induced ototoxicity].
    Ostroumova OD; Chikh EV; Rebrova EV; Ryazanova AY; Pereverzev AP
    Vestn Otorinolaringol; 2019; 84(4):72-80. PubMed ID: 31579063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of Hair Cells from Ototoxic Drug-Induced Hearing Loss.
    Guo J; Chai R; Li H; Sun S
    Adv Exp Med Biol; 2019; 1130():17-36. PubMed ID: 30915699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological intervention in the field of ototoxicity.
    Laurell G
    HNO; 2019 Jun; 67(6):434-439. PubMed ID: 30993373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity: therapeutic opportunities.
    Rybak LP; Whitworth CA
    Drug Discov Today; 2005 Oct; 10(19):1313-21. PubMed ID: 16214676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting.
    Harris T; Peer S; Fagan JJ
    J Laryngol Otol; 2012 Jun; 126(6):548-51. PubMed ID: 22459550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced hearing loss.
    Prescrire Int; 2014 Dec; 23(155):290-4. PubMed ID: 25629145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic ototoxicity: a review.
    Shine NP; Coates H
    East Afr Med J; 2005 Oct; 82(10):536-9. PubMed ID: 16450683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced tinnitus and other hearing disorders.
    Seligmann H; Podoshin L; Ben-David J; Fradis M; Goldsher M
    Drug Saf; 1996 Mar; 14(3):198-212. PubMed ID: 8934581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ototoxic drugs. I. Aminoglycoside antibiotics].
    Buszman E; Wrześniok D; Matusiński B
    Wiad Lek; 2003; 56(5-6):254-9. PubMed ID: 14526485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity.
    Mukherjea D; Dhukhwa A; Sapra A; Bhandari P; Woolford K; Franke J; Ramkumar V; Rybak L
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):965-982. PubMed ID: 32757852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ototoxicity of drugs].
    Fossati C
    Clin Ter; 1986 Jul; 118(2):137-43. PubMed ID: 2874911
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention and restoration of hearing loss associated with the use of cisplatin.
    Chirtes F; Albu S
    Biomed Res Int; 2014; 2014():925485. PubMed ID: 25140325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.